TNFRSF11B and rheumatoid arthritis: In view of these contradictory results, further studies are required to clarify the relevance of OPG in disease/progression activity in RA, and to examine whether this biomarker may be useful in combination with other risk factors to improve predictions and guide treatment decisions.